| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.|
Txns:
| Paid exercise price by delivering 34,442 shares
@ $21.16, valued at
$728.8k
Exercised 90,000 options to buy
@ $6, valued at
$540k
Granted 346,500 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.|
Txns:
| Paid exercise price by delivering 9,602 shares
@ $14.76, valued at
$141.7k
Exercised 23,000 options to buy
@ $0 |
|
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2020 |
4/A
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.|
Txns:
| Granted 57,000 options to buy
@ $7.3, valued at
$416.1k
Granted 23,000 restricted stock units
@ $0 |
|
| 01/06/2020 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.|
Txns:
| Granted 57,000 options to buy
@ $7.3, valued at
$416.1k
Granted 23,000 restricted stock units
@ $0 |
|
| 11/25/2019 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on HARROW HEALTH, INC.|
Txns:
| Exercised (in-or-at-the-money) 39,000 options to buy
@ $1.79, valued at
$69.8k
|
|
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2018 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.|
Txns:
| Exercised 30,000 shares
@ $1.83, valued at
$54.9k
Exercised 30,000 options to buy
@ $0 |
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2016 |
4
| BOLL ANDREW R. (CFO) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $3.95, valued at
$237k
|
|
| 05/08/2013 |
4
| Boll Andrew (VP ACCOUNTING AND REPORTING) has filed a Form 4 on Imprimis Pharmaceuticals, Inc.|
Txns:
| Granted 90,000 options to buy
@ $6, valued at
$540k
|
|
| 03/15/2013 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |